Endpoint definition
↥| Name | CD2_BENIGN_LIVE_BILE |
|---|---|
| Long name | Benign neoplasm: Liver/bile ducts |
| Include | CD2_BENIGN_LIVER, CD2_BENIGN_EXTRAHEPATIC_BILE |
| Level in the ICD-hierarchy | 3 |
| First defined in version | DF2 |
Benign neoplasm: Liver/bile ducts
biliary tract neoplasm: A benign or malignant neoplasm that affects the extrahepatic bile ducts. Representative examples include adenoma and adenocarcinoma.
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 264 | 191 | 73 |
| Unadjusted prevalence (%) | 0.12 | 0.16 | 0.08 |
| Mean age at first event (years) | 52.69 | 49.13 | 62.02 |
| Case fatality at 5-years (%) | 3.79 | 2.09 | 8.22 |
Longitudinal metrics
| All | Female | Male | |
|---|---|---|---|
| Median nb. of events per indiv. | 1.0 | 1.0 | 1.0 |
| Recurrence at 6 months (%) | 21.59 | 20.94 | 23.29 |
Survival analyses between endpoints
↥Plot
before Benign neoplasm: Liver/bile ducts
after Benign neoplasm: Liver/bile ducts
Loading survival analyses plot…
Table
Loading survival analyses table…